Toripalimab

Loqtorzi

Concentrato per soluzione per infusioneItalyAuthorised

In other countries

The same active substances on other registers, the same brand first.

LoqtorziCanada · 40 MG / ML · Solution · Apotex INCSame brand
Loqtorzi 240 MG Concentrado Para Solucion Para PerfusionSpain · 240 mg · concentrado para solución para perfusión · Topalliance Biosciences Europe LimitedSame brand
LoqtorziEuropean Union · Topalliance Biosciences Europe LimitedSame brand
LoqtorziCroatiaSame brand
LOQTORZI 240 mg concentraat voor oplossing voor infusieNetherlands · Concentraat voor oplossing voor infusie · Topalliance Biosciences Europe LimitedSame brand
Loqtorzi Concentrate for Solution for Infusion 240MG/6MLSingapore · 240mg/6mL · infusion, solution concentrate · Ta Biosciences Pte. LTD.Same brand

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Toripalimab

Loqtorzi

Concentrato per soluzione per infusioneItalyAuthorised

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

LoqtorziUnited States · 240MG/6ML · injectable · Coherus Biosciences INC

ZytorviBrazil · DR. Reddys Farmacêutica do Brasil Ltda

Packs

Pack	Code	Status
240 mg - Concentrato per soluzione per infusione - Uso endovenoso - flaconcino (vetro) 6 ml (40 mg/ml) - 1 flaconcino	051606010	Autorizzata

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Toripalimab
Dosage form: Concentrato per soluzione per infusione
Register: Italy (AIFA)
Status: Authorised
Status in the register: Autorizzata
Registration: AIC 051606
Marketing authorisation holder: Topalliance Biosciences Europe Limited
ATC code: L01FF13
Group: Antineoplastic and immunomodulating agents
Procedure: Procedura Centralizzata
Supply: Medicinali soggetti a prescrizione medica limitativa, utilizzabili esclusivamente in ambiente ospedaliero o in una struttura ad esso assimilabile